SLEEP-WAKE CYCLE IN CHEMOTHERAPY PATIENTS: A RETROSPECTIVE STUDY

被引:0
作者
Gonella, S. [1 ]
机构
[1] AOU San Giovanni Battista Torino, SC Ematol 1, I-10126 Turin, Italy
关键词
Sleep initiation and maintenance disorders; Neoplasms; Nursing care; Anxiety; CANCER; DISTURBANCE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SLEEP-WAKE CYCLE IN CHEMOTHERAPY PATIENTS: A RETROSPECTIVE STUDY Aim. Over 50% of cancer patients suffer from insomnia, nearly twice the estimated prevalence in the general population. However, this widespread problem has received far less attention compared to cancer pain and fatigue. The aim of this study was to determine whether certain factors can alter the sleep-wake cycle in this patient subgroup and whether altered nyctohemeral sleep rhythms may negatively impact on quality of life. Methods. The medical records of 101 patients treated at the Cancer Center, San Giovanni Battista Hospital, Turin, and who had died of cancer in 2007, were reviewed. Extracted from each record were data on: patient age, sex, primary tumor site, presence of pain, concomitant conditions, concomitant medications, type of therapy, chemotherapeutic (CT) scheme, survival, and side effects. The sample was divided into two subgroups defined as inducers or non-inducers, depending on whether the patient had taken medications or not to treat insomnia. Significant differences between the two groups for these variables were tested using statistical analysis. Results. A statistically significant difference between the two groups emerged for anxiety-depression syndromes (P=0.00001), the number of sleeping pills taken in association with a concurrent anxiety-depression syndrome (P=0.01463), and side effects (P=0.0015). There was a statistically significant difference between the inducer and the non-inducer groups for female sex (one-tailed Fisher's exact test; P=0.04170) but the difference was marginal on Fisher's two-tailed test (P=0.06121). No statistically significant differences between the two groups were found for mean age (P=0.61281), median age (P=0.9996), primary tumor site, concomitant conditions (P=0.4205), survival (P=0.5704), presence of pain (P=0.53300) or type of therapy (P=0.6466). Conclusion. Sleep disturbances are a common complaint of cancer patients but have only recently attracted greater attention as the diagnosis of cancer has increased. Sleep disturbances are not an isolated problem but rather lead to a vicious circle of insomnia and fatigue where it is not always possible to distinguish between cause and effect. Future studies are needed to gain insight into the underlying mechanisms and a better understanding of what causes alterations in circadian rhythm.
引用
收藏
页码:135 / 147
页数:13
相关论文
共 15 条
  • [1] Berger Ann Malone, 2008, J Natl Compr Canc Netw, V6, P3
  • [2] Sleep disturbance in cancer patients
    Davidson, JR
    MacLean, AW
    Brundage, MD
    Schulze, K
    [J]. SOCIAL SCIENCE & MEDICINE, 2002, 54 (09) : 1309 - 1321
  • [3] Donovan Kristine A, 2007, Semin Oncol Nurs, V23, P127, DOI 10.1016/j.soncn.2007.01.004
  • [4] Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: Evaluation of diagnostic criteria for cancer-related fatigue
    Fernandes, Roland
    Stone, Patrick
    Andrews, Paul
    Morgan, Rachael
    Sharma, Shanika
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2006, 32 (03) : 245 - 254
  • [5] Graci Gina, 2005, J Support Oncol, V3, P349
  • [6] Evaluation and Pharmacologic management of symptoms in cancer patients undergoing acute rehabilitation in a comprehensive cancer center
    Guo, Ying
    Young, Beth L.
    Hainley, Susan
    Palmer, Lynn
    Bruera, Eduardo
    [J]. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2007, 88 (07): : 891 - 895
  • [7] Sleep disturbance in supportive care of cancer: A review
    Kvale, Elizabeth A.
    Shuster, John L.
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2006, 9 (02) : 437 - 450
  • [8] Sleep disorders in advanced cancer patients: prevalence and factors associated
    Mercadante, S
    Girelli, D
    Casuccio, A
    [J]. SUPPORTIVE CARE IN CANCER, 2004, 12 (05) : 355 - 359
  • [9] O'Donnell Joseph F, 2004, Clin Cornerstone, V6 Suppl 1D, pS6, DOI 10.1016/S1098-3597(05)80002-X
  • [10] New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline
    Otaka, M
    Jin, M
    Odashima, M
    Matsuhashi, T
    Wada, I
    Horikawa, Y
    Komatsu, K
    Ohba, R
    Oyake, J
    Hatakeyama, N
    Watanabe, S
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 : 42 - 46